Related Experiment Videos
Affective disorders and suicide risk: a reexamination
1Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA. bostwick.john@mayo.edu
The American Journal of Psychiatry
|December 1, 2000
Summary
Suicide risk in affective disorders varies by treatment setting. Hospitalized patients, especially those with suicidal ideation, face a significantly higher lifetime risk than outpatients or the general population.
Area of Science:
- Psychiatry
- Mental Health Research
- Epidemiology
Background:
- A 1970 meta-analysis estimated suicide risk in affective illness at 15%, a figure widely generalized.
- This generalized estimate has been uncritically applied to all depressive disorders in numerous publications and textbooks.
- The current study questions the generalizability and accuracy of this long-standing estimate.
Purpose of the Study:
- To re-evaluate suicide risk in patients with affective disorders.
- To propose an alternative estimate of suicide risk based on treatment setting.
- To challenge the uncritical acceptance of the 1970 Guze and Robins estimate.
Main Methods:
- A literature search identified studies with data on suicide occurrence in affective illness.
- Studies were categorized into three groups: outpatients, inpatients, and suicidal inpatients.
- Suicide risks were calculated meta-analytically for these groups and previously published collections.
Main Results:
- A hierarchy of suicide risk was observed based on treatment intensity.
- Lifetime suicide prevalence was 8.6% for patients hospitalized for suicidality.
- Lifetime suicide prevalence was 4.0% for general affective disorder inpatients, 2.2% for mixed inpatient/outpatient groups, and <0.5% for nonaffectively ill populations.
Conclusions:
- Case fatality prevalence is a more appropriate measure of suicide risk than proportionate mortality prevalence.
- While affective disorders confer higher suicide risk than the general population, specific diagnostic subtypes are not reliable predictors.
- Hospitalization, particularly for suicidality, is a significant indicator of elevated suicide risk, suggesting treatment setting intensity is a key factor.